Arcutis Biotherapeutics, Inc. company logo
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. (ARQT) Cash From Financing

Annual CFF

$66.20M$35.12M-34.66%

Summary

Current Value
As of today, ARQT annual cash from financing is $66.20M, down -34.66% on
Historical Performance
ARQT annual cash from financing is down -76.52% over the past 3 years, and down -28.89% over the past 5 years
All-Time High Comparison
ARQT annual cash from financing is currently -78.06% below its historical high of $301.80M set on
3-Year Low Comparison
ARQT annual cash from financing is at its 3-year low
Sector Comparison
ARQT annual cash from financing is higher than 77.86% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ARQT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$66.20M-34.7%-76.5%-28.9%+829.9%
Quarterly Cash From Financing$1.48M+274.6%-99.5%+4241.2%
TTM Cash From Financing-$94.16M-135.8%-125.2%-135.7%
Price$29.88+95.7%+99.1%+6.1%
Annual Cash From Operations-$112.16M+54.6%+35.8%-161.8%-2871.1%
Annual Cash From Investing$28.82M-84.0%+137.9%+209.5%+100.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$110.59M-46.3%+42.6%+10000.0%+100.0%
Shares Outstanding122.49M+3.9%+100.7%+182.6%

Cash From Financing Highs

ARQT Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$301.80MN/A-78.1%
5Y$301.80M-78.1%
All$301.80M-78.1%

Cash From Financing Lows

ARQT Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$66.20Mat low
5Y$66.20Mat low
All$7.12M+829.9%

Cash From Financing History

YearValueChange
$66.20M-34.7%
$101.32M-66.4%
$301.80M+7.0%
$281.95M-5.4%
YearValueChange
$298.15M+220.2%
$93.10M+51.2%
$61.59M+765.2%
$7.12M-

FAQ

  • What is the current annual cash from financing of ARQT?

    As of today, ARQT annual cash from financing is $66.20M

  • What is 1-year change in ARQT annual cash from financing?

    ARQT annual cash from financing is down -34.66% year-over-year

  • What is 3-year change in ARQT annual cash from financing?

    ARQT annual cash from financing is down -76.52% over the past 3 years

  • How far is ARQT annual cash from financing from its all-time high?

    ARQT annual cash from financing is currently -78.06% below its historical high of $301.80M set on December 31, 2022

  • How does ARQT annual cash from financing rank versus sector peers?

    ARQT annual cash from financing is higher than 77.86% of companies in Healthcare sector

  • When is ARQT next annual earnings release?

    The next annual earnings release for ARQT is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. ARQT Official Website www.arcutis.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1787306/000178730625000144/0001787306-25-000144-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787306/000178730625000029/0001787306-25-000029-index.htm
  4. ARQT Profile on Yahoo Finance finance.yahoo.com/quote/ARQT
  5. ARQT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arqt